UNSPSC 51434916: Bendroflumethiazide/rauwolfia serpentina

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434916 Bendroflumethiazide/rauwolfia serpentina is a Commodity code that does not match the work being solicited under it in recent state and local activity. The single recent opportunity tagged to this code—a City of Tampa Fire Rescue procurement for Advanced Life Support Medications—solicits labetalol, epinephrine, adenosine, and diltiazem injections and vials, none of which are bendroflumethiazide or rauwolfia serpentina compounds. The mismatch indicates either a tagging error or a misalignment between the code's pharmaceutical scope and how the jurisdiction classified this emergency medical supply procurement. State and local governments buying under this code designation would typically acquire pharmaceutical products for emergency medical services, public health departments, or clinical settings, but the recent activity provides no additional context on issuing-body types or repeat buyers.

The City of Tampa Purchasing Department issued an IFB (Bid No. 26P00188) on April 24, 2026, with a due date of April 8, 2026, for emergency life support medications to supply Tampa Fire Rescue in Hillsborough County, Florida. The contract was estimated at $40,000.00 and carried a one-year term with two optional one-year renewals and three optional 30-day extensions. The City designated the procurement as sheltered for Small Local Business Enterprises with a 5 percent bid discount capped at $10,000, and required all vendors to submit OSHA-compliant Safety Data Sheets and WCAG 2.2 Level AA accessibility documentation. Beyond this single Tampa Fire Rescue solicitation, the code shows no other recent state or local opportunities.